Max Robotics — Global Service Robot Directory + US Certification

About

Marco Del Chiaro is a world-renowned pancreatic surgeon and researcher whose work has fundamentally shaped the field of minimally invasive pancreatic surgery. His primary research areas include the surgical management of pancreatic cancer, minimally invasive and robotic pancreatectomy, and the treatment of intraductal papillary mucinous neoplasms (IPMNs). Del Chiaro’s most significant contribution is his leadership in developing the first evidence-based guidelines for minimally invasive pancreas resection (MIPR), published in 2019 with 478 citations, which established global standards for these complex procedures. He also led the landmark DIPLOMA study (280 citations), a multicenter trial comparing minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma, providing crucial evidence on oncological outcomes. Additionally, he co-authored expert consensus guidelines on managing the pancreatic transection plane after distal pancreatectomy (73 citations). His recent work on intraoperative pancreatoscopy during robotic pancreatectomies for IPMNs demonstrates his continued innovation. With a career spanning pioneering clinical trials and guideline development, Del Chiaro’s research has directly improved surgical safety and patient outcomes worldwide.